The global external ventricular drain market size was valued at USD 5.86 billion in 2020 and is expected to reach 9.85 billion by 2027 at a compound annual growth rate (CAGR) of 7.7 % . Rising incidence of neurological disorders and increasing road accidents which results in traumatic brain injuries are major factors driving the market for external ventricular drains. In addition, increasing research activities and rising adoption of technologically advanced products are few other factors contributing towards market growth.
According to the WHO, neurovascular stroke is the second most common cause of death and the third most common cause of disability around the world and approximately 60%-80% of all strokes are ischemic. This occurs due to blocked blood vessels which limits the blood supply to the brain or when a weakened blood vessel bursts and bleeds into the surrounding brain. Since, the last four years, the incidence rate of strokes majorly in low- and middle-income countries has increased more than double. For instance, India has a very high incidence rate of ischemic stroke and is one of the leading causes of death. According to a recent study by All India Institute of Medical Sciences (AIIMS) 2016, approximately 1.8 million Indians suffer from cerebrovascular stroke every year. Additionally, around 1.1 million people in Europe suffer from ischemic stroke every year. Thus, a high incidence of cerebrovascular disorders may lead to intraventricular bleeding (hemorrhage), which in turn demands the use of ventricular drain sets to remove the excess cerebrospinal fluid. This is expected to drive the market for external ventricular drain over the forecast period.
Moreover, the increasing incidence of cranial injuries and trauma across the world is a key driver of the market for external ventricular drains. Road accidents fall and sports injuries are the most common causes of head trauma, and cranial injuries. This results in hospitalization and permanent disability for thousands of individuals every year. Raised intracranial pressure (ICP) after a head injury is considered to have an adverse effect with a mortality rate of around 20%. Thus, continuous monitoring of intracranial pressure is crucial to map the progression of brain injury. As per the WHO, vehicle injuries are projected to be the ninth leading cause of death worldwide. Similarly, according to the Association for Safe International Road Travel 2018 report, about 20-50 million people are injured or disabled every year owing to road accidents. Thus, in the U.S., falls (52%) and road accidents (20%) are the first and second leading causes of all traumatic brain injury-related hospitalizations, respectively. This, in turn, will boost the demand for an external ventricular drain for the treatment.
The traumatic brain injury segment dominated the market for external ventricular drains with a share of 33.7% in 2019. The increasing prevalence of traumatic brain injuries due to road accidents falls and violence is contributing towards the segment growth. Such injuries lead to hospitalization and permanent disability for thousands of individuals each year. For instance, as per the European Injury Database (IDB), approximately 6.1 million people are treated in hospitals for injuries every year. These injuries include facial and traumatic brain injuries. Similarly, according to the CDC report, an estimated 56,000 seniors are hospitalized every year as a result of head injuries suffered due to falls and 775,000 older adults are living with traumatic brain injury-related disability. This is expected to fuel segment growth during the forecast period.
Furthermore, conditions such as hydrocephalus affect a large number of people across the world. For instance, as per the Hydrocephalus Association, over 1.0 million people are currently suffering from hydrocephalus in the U.S., which is the most common reason for brain surgery. Similarly, over 750,000 people in America are living with normal pressure hydrocephalus (NPH). It is estimated that more than 400,000 babies suffer from infant hydrocephalus each year globally. Such a high prevalence of neurovascular disorders along with the rising number of brain surgeries is expected to boost the growth of the market for external ventricular drain during the forecast period.
The Extra Ventricular Market is segmented on the basis of application and region. On the basis of application Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Other Non-traumatic Hydrocephalus Conditions.
North America dominated the external ventricular drain market with a share of 35.6% in 2019. This is owing to the greater incidence of traumatic brain injuries as well as the high prevalence of neurovascular disorders. For instance, as per the CDC, stroke is the fifth leading cause of death and more than 140,000 people are killed due to cerebrovascular stroke each year in the U.S. Furthermore, rapid technological advancements and the presence of major medical equipment companies such as Medtronic, and Integra LifeSciences are also contributing towards the growth of the market for the external ventricular drain in the region. Thus, the increasing prevalence of neurovascular disorders and brain injuries as well as growing awareness among individuals about associated disorders and treatment are driving the market for external ventricular drains.
In the Middle East & Africa (MEA), the market for the external ventricular drain is expected to witness the highest CAGR of 8.2% from 2020 to 2027. This is due to the presence of such a huge patient base in the emerging economies, along with rising healthcare expenditures in this region. For instance, according to the International Federation for Spina Bifida and Hydrocephalus, over 375,000 new cases of infant hydrocephalus are reported in sub-Saharan Africa each year. In addition, increasing incidence of road accidents in the MEA countries is rising at an alarming rate and is now the leading cause of mortality among young adults, thereby, expected to propel the growth of the market for external ventricular drain during the forecast period. As per the WHO report, a road-traffic mortality rate of 26.6 deaths per 100,000 people has been registered in this continent.
Key companies are: Spiegelberg GmbH & Co. KG; Medtronic; Sophysa; Dispomedica GmbH; Integra LifeSciences; Möller Medical GmbH; B. Braun Melsungen AG; Fuji Systems.
According to the WHO, neurovascular stroke is the second most common cause of death and the third most common cause of disability around the world and approximately 60%-80% of all strokes are ischemic. This occurs due to blocked blood vessels which limits the blood supply to the brain or when a weakened blood vessel bursts and bleeds into the surrounding brain. Since, the last four years, the incidence rate of strokes majorly in low- and middle-income countries has increased more than double. For instance, India has a very high incidence rate of ischemic stroke and is one of the leading causes of death. According to a recent study by All India Institute of Medical Sciences (AIIMS) 2016, approximately 1.8 million Indians suffer from cerebrovascular stroke every year. Additionally, around 1.1 million people in Europe suffer from ischemic stroke every year. Thus, a high incidence of cerebrovascular disorders may lead to intraventricular bleeding (hemorrhage), which in turn demands the use of ventricular drain sets to remove the excess cerebrospinal fluid. This is expected to drive the market for external ventricular drain over the forecast period.
Moreover, the increasing incidence of cranial injuries and trauma across the world is a key driver of the market for external ventricular drains. Road accidents fall and sports injuries are the most common causes of head trauma, and cranial injuries. This results in hospitalization and permanent disability for thousands of individuals every year. Raised intracranial pressure (ICP) after a head injury is considered to have an adverse effect with a mortality rate of around 20%. Thus, continuous monitoring of intracranial pressure is crucial to map the progression of brain injury. As per the WHO, vehicle injuries are projected to be the ninth leading cause of death worldwide. Similarly, according to the Association for Safe International Road Travel 2018 report, about 20-50 million people are injured or disabled every year owing to road accidents. Thus, in the U.S., falls (52%) and road accidents (20%) are the first and second leading causes of all traumatic brain injury-related hospitalizations, respectively. This, in turn, will boost the demand for an external ventricular drain for the treatment.
The traumatic brain injury segment dominated the market for external ventricular drains with a share of 33.7% in 2019. The increasing prevalence of traumatic brain injuries due to road accidents falls and violence is contributing towards the segment growth. Such injuries lead to hospitalization and permanent disability for thousands of individuals each year. For instance, as per the European Injury Database (IDB), approximately 6.1 million people are treated in hospitals for injuries every year. These injuries include facial and traumatic brain injuries. Similarly, according to the CDC report, an estimated 56,000 seniors are hospitalized every year as a result of head injuries suffered due to falls and 775,000 older adults are living with traumatic brain injury-related disability. This is expected to fuel segment growth during the forecast period.
Furthermore, conditions such as hydrocephalus affect a large number of people across the world. For instance, as per the Hydrocephalus Association, over 1.0 million people are currently suffering from hydrocephalus in the U.S., which is the most common reason for brain surgery. Similarly, over 750,000 people in America are living with normal pressure hydrocephalus (NPH). It is estimated that more than 400,000 babies suffer from infant hydrocephalus each year globally. Such a high prevalence of neurovascular disorders along with the rising number of brain surgeries is expected to boost the growth of the market for external ventricular drain during the forecast period.
The Extra Ventricular Market is segmented on the basis of application and region. On the basis of application Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Other Non-traumatic Hydrocephalus Conditions.
North America dominated the external ventricular drain market with a share of 35.6% in 2019. This is owing to the greater incidence of traumatic brain injuries as well as the high prevalence of neurovascular disorders. For instance, as per the CDC, stroke is the fifth leading cause of death and more than 140,000 people are killed due to cerebrovascular stroke each year in the U.S. Furthermore, rapid technological advancements and the presence of major medical equipment companies such as Medtronic, and Integra LifeSciences are also contributing towards the growth of the market for the external ventricular drain in the region. Thus, the increasing prevalence of neurovascular disorders and brain injuries as well as growing awareness among individuals about associated disorders and treatment are driving the market for external ventricular drains.
In the Middle East & Africa (MEA), the market for the external ventricular drain is expected to witness the highest CAGR of 8.2% from 2020 to 2027. This is due to the presence of such a huge patient base in the emerging economies, along with rising healthcare expenditures in this region. For instance, according to the International Federation for Spina Bifida and Hydrocephalus, over 375,000 new cases of infant hydrocephalus are reported in sub-Saharan Africa each year. In addition, increasing incidence of road accidents in the MEA countries is rising at an alarming rate and is now the leading cause of mortality among young adults, thereby, expected to propel the growth of the market for external ventricular drain during the forecast period. As per the WHO report, a road-traffic mortality rate of 26.6 deaths per 100,000 people has been registered in this continent.
Key companies are: Spiegelberg GmbH & Co. KG; Medtronic; Sophysa; Dispomedica GmbH; Integra LifeSciences; Möller Medical GmbH; B. Braun Melsungen AG; Fuji Systems.
- Aerospace and Defense
- Agriculture
- Automotive and Transportation
- Business and Finance
- Chemical and Materials
- Consumer Goods and Retails
- Electronics and Semiconductor
- Energy and Power
- Food and Beverages
- Machinery and Equipment
- Manufacturing and Construction
- Medical Devices
- Pharmaceuticals and Healthcare
- Service and Software
- Technology, Media and Telecommunications
- Travel and Tourism
